This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

Glenmark Pharma share price target 2024: Brokerage house Motilal Oswal has revised its ratings for Glenmark Pharma. It has upgraded its ratings for the firm from "Neutral" to a "Buy," increasing ...

Glenmark Pharmaceuticals, for its part, issued voluntary recalls for 90,528 bottles of the high blood pressure drug diltiazem hydrochloride in tablet and extended-release forms due to unacceptable ...

Shares of Glenmark Pharma surged over 4 percent in early trade on December 10 after the company stated that the first clinical data of its blood cancer drug showed a positive response rate of ...

Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. India's Glenmark Pharma posts Q2 profit on strong ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of lacosamide oral solution, 10 mg/mL. Glenmark’s lacosamide oral solution, 10 mg/mL is bioequivalent and therapeutically equivalent ...

Shares of Natco, Glenmark and Aurobindo Pharma are up 14, 10 and 2 percent respectively in the session. Developed by Pfizer, abrocitinib has received marketing authorisation from the Central Drugs ...

India’s Glenmark Pharma has added to its oncology pipeline by licensing rights to a checkpoint inhibitor from China’s Jiangsu Alphamab Biopharmaceuticals and 3D Medicines in markets outside ...

The company said the tablet is the bioequivalent and therapeutically equivalent to the Theophylline extended-release tablets, 300 mg and 450 mg, of Alembic Pharmaceuticals Limited. Glenmark ...